Takaoka M - Search Results

1

Proteasome participates in the pathogenesis of ischemic acute renal failure in rats.

Takaoka M, Itoh M, Hayashi S, Kuro T, Matsumura Y. Takaoka M, et al. Eur J Pharmacol. 1999 Nov 12;384(1):43-6. doi: 10.1016/s0014-2999(99)00664-0. Eur J Pharmacol. 1999. PMID: 10611418

2

Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.

Matsumura Y, Hisaki K, Takaoka M, Morimoto S. Matsumura Y, et al. Among authors: takaoka m. Eur J Pharmacol. 1990 Aug 21;185(1):103-6. doi: 10.1016/0014-2999(90)90216-s. Eur J Pharmacol. 1990. PMID: 2226629

3

Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats.

Matsumura Y, Fujita K, Takaoka M, Morimoto S. Matsumura Y, et al. Among authors: takaoka m. Eur J Pharmacol. 1993 Jan 5;230(1):89-93. doi: 10.1016/0014-2999(93)90414-d. Eur J Pharmacol. 1993. PMID: 8094056

4

Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.

Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S. Fujita K, et al. Among authors: takaoka m. Eur J Pharmacol. 1995 Jul 14;280(3):311-6. doi: 10.1016/0014-2999(95)00216-8. Eur J Pharmacol. 1995. PMID: 8566099

5

A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats.

Okamoto H, Takaoka M, Ohkita M, Itoh M, Nishioka M, Matsumura Y. Okamoto H, et al. Among authors: takaoka m. Eur J Pharmacol. 1998 May 29;350(1):R11-2. doi: 10.1016/s0014-2999(98)00327-6. Eur J Pharmacol. 1998. PMID: 9683028

6

Antihypertensive effect of a proteasome inhibitor in DOCA-salt hypertensive rats.

Takaoka M, Okamoto H, Ito M, Nishioka M, Kita S, Matsumura Y. Takaoka M, et al. Life Sci. 1998;63(4):PL65-70. doi: 10.1016/s0024-3205(98)00276-8. Life Sci. 1998. PMID: 9698041

7

Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.

Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M. Matsumura Y, et al. Among authors: takaoka m. Hypertension. 1999 Feb;33(2):759-65. doi: 10.1161/01.hyp.33.2.759. Hypertension. 1999. PMID: 10024341

8

Protective effect of KB-R7943, a novel Na+/Ca2+ exchange inhibitor, on ischemic acute renal failure in rats.

Kuro T, Kobayashi Y, Takaoka M, Matsumura Y. Kuro T, et al. Among authors: takaoka m. Jpn J Pharmacol. 1999 Oct;81(2):247-51. doi: 10.1254/jjp.81.247. Jpn J Pharmacol. 1999. PMID: 10591486 Free article.

9

Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats.

Matsumura Y, Kuro T, Konishi F, Takaoka M, Gariepy CE, Yanagisawa M. Matsumura Y, et al. Among authors: takaoka m. Br J Pharmacol. 2000 Mar;129(6):1060-2. doi: 10.1038/sj.bjp.0703157. Br J Pharmacol. 2000. PMID: 10725252 Free PMC article.

10

Selective antagonism of the ETA receptor, but not the ETB receptor, is protective against ischemic acute renal failure in rats.

Kuro T, Kohnou K, Kobayashi Y, Takaoka M, Opgenorth TJ, Wessale JL, Matsumura Y. Kuro T, et al. Among authors: takaoka m. Jpn J Pharmacol. 2000 Apr;82(4):307-16. doi: 10.1254/jjp.82.307. Jpn J Pharmacol. 2000. PMID: 10875750 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters